FlandersBio on Twitter

Follow us on Twitter

Life sciences database

Databank life sciences

in het nederlands in english

FlandersBio offers an up-to-date life sciences database with detailed information about all FlandersBio members.

FlandersBio beschikt over een geüpdate life sciences databank met een gedetailleerd overzicht van alle FlandersBio-ledenbedrijven.

Apitope International

Website: http://www.apitope.com
Email:
Phone: +32 11 28 69 00
FlandersBio Member
More address details

Business Focus

Apitope focuses on immunotherapies for the treatment of autoimmune and allergic diseases, including multiple sclerosis, factor VIII intolerance, uveitis and Graves’ disease. Apitope has a discovery platform which enables the selection of highly specific disease-modifying peptide therapies. These therapies selectively reinstate immune tolerance to the disease target of interest. Apitope has generated a pipeline of 6 clinical and preclinical programmes. The lead programme is partnered with Merck Serono.

Tags

Company Profile

Apitope is a European biotech company focused on the discovery and development of disease modifying peptide therapies for autoimmune and allergic diseases. Apitope’s aim is to become the company of choice for the development of disease modifying therapies for chronic autoimmune and allergic disorders, addressing critical unmet need. The Apitope discovery platform enables the discovery of therapies that selectively treat the underlying cause of disease rather than the symptoms. The company is headquartered in Hasselt, Belgium and has a wholly owned subsidiary in Bristol, UK.

Science & Technology or Services

Apitope has patented technology allowing the design of peptide therapeutics (Apitopes®) for autoimmune diseases. The novel Apitope technology is based on well established scientific evidence showing that soluble, synthetic peptides can reinstate tolerance and attenuate pathological immune responses. The therapy is specifically designed from naturally occurring antigenic proteins to selectively inhibit the immune system's harmful attack on the body while preserving the normal immune response to harmful antigens, such as infections.

The unique Apitope peptides function as tolerogens, exerting their therapeutic effect via a highly selective immune re-balancing process that, in pre-clinical studies, has been linked to the induction of IL- 10 secreting regulatory T cells. Behaving as Antigen Processing Independent epiTOPES (Apitopes®), the peptides induce tolerance to abnormal immune responses.

The company is testing the safety and efficacy of Apitopes® in multiple sclerosis. Its lead product is ATX-MS-1467, a potentially disease-modifying therapy specifically designed from a naturally occurring antigenic protein to selectively inhibit the immune system's harmful attack on the nervous system. The normal immune response to infection is preserved. The ATX-MS-1467 product candidate contains soluble, synthetic Apitopes® that reinstate tolerance and decrease the immune response to self-antigens. ATX-1467 is currently in Phase II of clinical development with Merck Serono. The product candidate for factor VIII intolerance has entered into preclinical development. The company is also developing therapies for other chronic diseases including Graves’ disease and Uveitis.

More info

Address: BioVille
Agoralaan Building A-bis
3590 Diepenbeek
Belgium

Route: Via Google Maps
Website: http://www.apitope.com

Phone: +32 11 28 69 00
Foundation date: 2008
Email: keith.martin@apitope.com

Become a Member

Listen to some testimonials from companies that are a member of FlandersBio and discover the benefits of membership

Read more

Z Life Sciences

Looking behind the scenes of the vibrant life sciences sector in Flanders!

YouTube

Biotechstockmarket

Belgian biotech on Euronext

Belgian biotech on Euronext

FlandersBio Members

VIB Intrexon Actobiotics Alexion Pharma Belgium BVBA Viziphar Biosciences KU Leuven - BioSCENTer Clever Consult Akcelis Janssen Diagnostics ALTIUS CropDesign reMYND Antwerp University Hospital Histogenex PMV ImprovementatWork Rode Kruis-Vlaanderen AX’S Consulting GrayMatters Consulting Cistim Sanofi Belgium Syngulon Medanex Clinic AML Clinical Services Millibeter Sourcia BIPP, BIP eProcurement Platform for Life Sciences HAZGO CoBioRes Panaxea

View all members

Life Sciences Map

Life Sciences Map

View Life Sciences Map

Back to top

Print